ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 171

Development and Acceptability of an Adolescent Self-management Program for Juvenile Idiopathic Arthritis

Kelsey Chomistek1, Cheryl Barnabe 2, Katie Birnie 3, Julia Brooks 4, Tracey Clancy 5, Syeda Farwa Naqvi 5, Nadia Luca 5, Maggie Mercer 4, Maria Santana 5, Jennifer Stinson 6, Aynsley Wennberg 4 and Heinrike Schmeling 7, 1Calgary, Alberta, Canada, 2University of Calgary, Calgary, Alberta, Canada, 3Alberta Children's Hospital, Calgary, Canada, 4Alberta Children's Hospital, Calgary, Alberta, Canada, 5University of Calgary, Calgary, Canada, 6University of Toronto & The Hospital for Sick Children, Toronto, Ontario, Canada, 7Alberta Children's Hospital/University of Calgary, Calgary, Alberta, Canada

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: juvenile idiopathic arthritis (JIA), Self-management

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: Needs assessments have revealed an urgent need for disease information, self-management skills, and peer support for patients with juvenile idiopathic arthritis (JIA). Our aim was to develop and test the acceptability of an in-person and teleconference self-management program (SMP) to address these needs in adolescents with JIA.

Methods: Development phase: The SMP was developed through literature review, Lorig’s self-management theory, needs assessments of patients with JIA, and the existing evidence-base for effective SMPs. Additional input was obtained from key informants, including adolescents with JIA and interdisciplinary pediatric rheumatology team members.

 Acceptability phase: A qualitative study with semi-structured focus groups was conducted to determine the acceptability of the SMP. Purposive sampling was used to recruit patients meeting the following inclusion criteria: a) ages 12-17, b) confirmed diagnosis of JIA according to the International League of Associations for Rheumatology classification criteria, c) receiving rheumatology care at the Alberta Children’s Hospital, and d) sufficient English skills. Two groups of 4 adolescents with JIA (n = 8 (50% male), mean age = 13.5, SD = 0.8, mean disease duration = 2.9 years) participated in 4 focus groups. Content analysis was used to analyze the data.

Results: Development phase: The SMP structure consists of four, 1.5 hour group sessions designed to be delivered in-person or by teleconference by pediatric rheumatology health professionals. The sessions are titled: 1) Overview and diagnosis of JIA; 2) Daily living and exercise; 3) Coping strategies; and 4) Treatment and lifestyle management. Each session includes a power point presentation, interactive activities, and discussions.

 Acceptability phase: Participants supported a group-based SMP delivered in-person and/or via teleconference, reflecting it would provide the opportunity for peer support in a small-group setting (4-6 adolescents). Participants advised that a rheumatology healthcare provider should facilitate the session to increase the trustworthiness of the information provided and answer questions. Participants felt the content was appropriate and would be effective in supporting self-management of their JIA. Potential barriers to participation included distance and availability, but the option for teleconference-based participation was an appropriate solution. Weekday evenings/weekend afternoons were preferred times to attend the SMP. Adolescents provided suggestions for improvement (e.g. improved efficiency by reducing content to three sessions, and providing additional time for breaks/groups discussions and peer-support). Minor changes to the SMP have been made to reflect these recommendations.

Conclusion: This is the first evidence-based in-person/teleconference JIA SMP in Canada. The SMP was well received by the adolescents and the inclusion of a teleconference option was an innovative solution to improve accessibility. This study proved the acceptability of the SMP prior to conducting a randomized controlled effectiveness trial, with the ultimate aim of widespread program implementation.


Disclosure: K. Chomistek, None; C. Barnabe, None; K. Birnie, None; J. Brooks, None; T. Clancy, None; S. Naqvi, None; N. Luca, None; M. Mercer, None; M. Santana, None; J. Stinson, None; A. Wennberg, None; H. Schmeling, None.

To cite this abstract in AMA style:

Chomistek K, Barnabe C, Birnie K, Brooks J, Clancy T, Naqvi S, Luca N, Mercer M, Santana M, Stinson J, Wennberg A, Schmeling H. Development and Acceptability of an Adolescent Self-management Program for Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/development-and-acceptability-of-an-adolescent-self-management-program-for-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-acceptability-of-an-adolescent-self-management-program-for-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology